MedPath

南京制药厂有限公司

Ownership
-
Established
1991-07-11
Employees
-
Market Cap
-
Website
www.nanjing-pharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

52

NMPA:52

Drug Approvals

Clodronate Disodium Injection

Product Name
氯膦酸二钠注射液
Approval Number
国药准字H20065587
Approval Date
Apr 29, 2021
NMPA

Ifosfamide

Product Name
异环磷酰胺
Approval Number
国药准字H20066725
Approval Date
Apr 21, 2021
NMPA

Ifosfamide for Injection

Product Name
注射用异环磷酰胺
Approval Number
国药准字H20066726
Approval Date
Apr 21, 2021
NMPA

Azasetron Hydrochloride Injection

Product Name
盐酸阿扎司琼注射液
Approval Number
国药准字H20010106
Approval Date
Oct 21, 2020
NMPA

Sodium Demethylcantharidate for Injection

Product Name
注射用去甲斑蝥酸钠
Approval Number
国药准字H20060309
Approval Date
Sep 9, 2020
NMPA

Famotidine

Product Name
法莫替丁
Approval Number
国药准字H32024220
Approval Date
Sep 4, 2020
NMPA

Diisopropylamine Ascorbate

Product Name
维丙胺
Approval Number
国药准字H32025454
Approval Date
Sep 4, 2020
NMPA

Clodronate Disodium Tablets

Product Name
氯膦酸二钠片
Approval Number
国药准字H19980058
Approval Date
Sep 4, 2020
NMPA

Hymecromone

Product Name
羟甲香豆素
Approval Number
国药准字H32021387
Approval Date
Sep 4, 2020
NMPA

Proglumide

Product Name
丙谷胺
Approval Number
国药准字H32021383
Approval Date
Sep 4, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.